3 Cheap Artificial Intelligence Stocks to Buy Right Now

The article argues that Microsoft, Meta Platforms, and Nvidia are undervalued AI leaders, citing Microsoft’s $37 billion AI annual run rate, Azure revenue growth of 40%, Meta’s 33% revenue growth, and Nvidia’s expected 41% earnings growth next year. Microsoft is said to trade at 20.4x fiscal 2027 earnings, below the S&P 500’s 21.5x forward P/E, while Meta and Nvidia also screen as inexpensive relative to growth. This is primarily bullish valuation commentary rather than new fundamental news, so the likely market impact is limited.

Analysis

The market is treating these as one crowded AI basket, but the setup is different across the three names. MSFT and NVDA are the cleaner second-order beneficiaries of continued capex because they monetize the build-out itself, while META is more of a lagged winner: it can absorb AI spend if ad pricing and engagement stay resilient, but it needs proof that incremental AI dollars improve ROI rather than just inflate expense. The key distinction is duration—NVDA is a 12-18 month earnings re-rate story if hyperscaler budgets hold, MSFT is a longer-duration compounding story tied to cloud workload migration, and META is the most vulnerable to any slowdown in ad demand or a slip in AI monetization.

The consensus is probably underestimating how much of the “AI trade” is now a capital-allocation trade. If hyperscalers keep spending aggressively, the winners expand beyond the obvious chip/software leaders into power, networking, and cooling infrastructure; if they pause, the multiple compression will hit the entire complex before fundamentals roll over. That means the biggest hidden risk here is not model adoption, but budget cadence: one quarter of softer capex guidance from a major platform can knock 10-15% off supplier sentiment even if end-demand remains intact.

The contrarian point is that “cheap vs the index” may be the wrong anchor for these names. Their earnings quality and growth duration are materially above the market, so the real question is whether current prices already discount a normalization in AI growth rates over the next 2-3 quarters. If the market begins to price in a second derivative slowdown in 2027 growth, NVDA is the most exposed to disappointment; if instead AI spend broadens into enterprise workloads, MSFT has the best asymmetry because it can reaccelerate multiple expansion without needing a narrative breakthrough.

Key Decisions for Investors

• Go long MSFT on any 3-5% pullback over the next 2-4 weeks; best risk/reward among the trio because it combines durable AI monetization with lower execution risk than META and less sentiment sensitivity than NVDA.
• Maintain a tactical long NVDA, but hedge with a short-dated call spread sale against the position; the trade works if capex stays firm, while limiting downside if the market starts discounting a 2027 growth air pocket.
• Avoid chasing META into strength until there is evidence that AI spend is improving ad ROI; if you want exposure, use a phased entry over 6-8 weeks because it is the most dependent on a positive earnings revision cycle.
• Pair trade: long MSFT / short a basket of higher-multiple AI beneficiaries with weaker cash conversion; this captures the quality spread if the market rotates from narrative to fundamentals.
• For higher-conviction risk capital, buy NVDA Jan-2027 calls on weakness; payoff is asymmetric if hyperscaler spending stays elevated, but keep size modest because the name is most vulnerable to capex deceleration headlines.